Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1656 Monotherapy in Japanese T2DM Patients
NCT01152385Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- May 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD1656 in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started May 2010; status: completed.
02
Drugs
AZD1656
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01152385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01152385.